SPONSOR

Second Affiliated Hospital, Zhejiang University, School of Medicine

Total Trials

Recruiting

Phases

Phase 4, Phase 1, Phase 2, Phase 1, Phase 2, Phase 3

Conditions studied: Ulcerative Colitis Inflamatory Bowel Disease Idiopathic Normal Pressure Hydrocephalus Breast Cancer Anemia Iron Deficiency Anemia Perioperative Transfusion Cardiac Surgery Anterior Cruciate Ligament Injuries

Second Affiliated Hospital, Zhejiang University, School of Medicine is a clinical research sponsor with 51 registered studies on ClinicalTrials.gov, of which 51 are actively recruiting participants. Research covers conditions including Ulcerative Colitis, Inflamatory Bowel Disease, Idiopathic Normal Pressure Hydrocephalus, Breast Cancer.

The trial portfolio spans Phase 4, Phase 1, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Frequently Asked Questions — Second Affiliated Hospital, Zhejiang University, School of Medicine

How many clinical trials has Second Affiliated Hospital, Zhejiang University, School of Medicine sponsored?

ClinicalMetric currently tracks 51 clinical trials sponsored by Second Affiliated Hospital, Zhejiang University, School of Medicine, of which 51 are actively recruiting participants. These trials cover conditions including Ulcerative Colitis, Inflamatory Bowel Disease, Idiopathic Normal Pressure Hydrocephalus. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.

What therapeutic areas does Second Affiliated Hospital, Zhejiang University, School of Medicine research focus on?

Second Affiliated Hospital, Zhejiang University, School of Medicine clinical trials span Ulcerative Colitis, Inflamatory Bowel Disease, Idiopathic Normal Pressure Hydrocephalus, Breast Cancer, Anemia, and additional conditions. The research pipeline includes Phase 4, Phase 1, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.

How do I participate in a Second Affiliated Hospital, Zhejiang University, School of Medicine clinical trial?

To participate in a Second Affiliated Hospital, Zhejiang University, School of Medicine trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Second Affiliated Hospital, Zhejiang University, School of Medicine trials with current recruitment status updated daily.

Second Affiliated Hospital, Zhejiang University, School of Medicine

Frequently Asked Questions — Second Affiliated Hospital, Zhejiang University, School of Medicine

Clinical Trials by Second Affiliated Hospital, Zhejiang University, School of Medicine

Study of the Effect of Vedolizumab on Intestinal Microecological Changes and Its Efficacy in the Treatment of Ulcerative Colitis

A Prospective Cohort Study Evaluating the Efficacy and Safety of Guselkumab (GUS) With JAK Inhibitors in Patients With Difficult-To-Treat Inflammatory Bowel Disease (IBD)

Multi-omics Research of Idopathic Normal Pressure Hydrocephalus (iNPH)

A Study for the Neoadjuvant Treatment of Breast Cancer

The Effect of Combined Iron Protocols on Perioperative Allogeneic Transfusion

Arthroscopic Anterior Cruciate Ligament Repair Versus Reconstruction for Acute Anterior Cruciate Ligament Injury

Effects of TDCS Intervention on Neoadjuvant Chemotherapy in Breast Cancer Patients with Mild to Moderate Depression

Drug Sensitivity of Hydrothorax and Ascite Organoids from Breast Cancer

Ixazomib Plus Low-dose Lenalidomide Versus Ixazomib Alone for Maintenance Treatment of High Risk Multiple Myeloma

Effects of Agent-assisted, LLM-assisted and Traditional Workflows on Diagnosis and Management Planning at Admission

Sequential Treatment of CD19 CARNK and 7x19 CAR-T in R/R B Cell Lymphoma

Prospective Cohort Study of Intracerebral Hemorrhage

Intensified Adjuvant Therapy for High-Risk Newly Diagnosed Glioblastoma With Subtotal Resection or Short-Term Progression

Construction of a Prospective Cohort Database for the Perioperative Period of Cardiac Surgery

Clinical Study of ATTR-CM

Orelabrutinib, Sintilimab and Temozolomide in Relapsed or Refractory Central Nervous System Lymphoma

Leucine Plus Radiochemotherapy for Neoadjuvant Treatment of Locally Advanced Rectal Cancer

Microneedle Intra-Arterial Injection for Retinal Artery Occlusion

Efficacy and Safety of Telitacicept in the Treatment of Systemic Sclerosis

Multi Center Observation of Sentinel Skin Graft for Detecting Acute Rejection After Renal Transplantation

Application of an Early In-Hospital Temperature Management Protocol for Heat Stroke Patients

Gao's Triple Eversion Carotid Endarterectomy

Clinical Study of Combined EphA2-targeted CAR-DC and CAR-T Cell Therapy for Non-small Cell Lung Cancer

Application of CIELab Spectrophotometry to Analyze Gingival Color: a New Perspective for Evaluating the Effectiveness of Periodontal Basic Treatment

Routine Angiography Follow-Up After Percutaneous Coronary Intervention in High-Risk Patients

Multicenter iTBS Neuromodulation for PTSD Treatment

AI-assisted Diagnosis of Malignant Brain Tumors

Camrelizumab, Chemotherapy and Ivarmacitinib in Patients With Resectable Esophageal Squamous Cell Carcinoma

Raman Spectroscopy-Based Deep Learning Model for Early Pan-Cancer Early Diagnosis

RAINBOW-ICH Trial of AI Guided Minimally Invasive Neurosurgery for ICH

Regional or Extend LymphAdenectomy During Resection of Intrahepatic Cholangiocarcinoma

SKB264 Plus Glecirasib in Advanced KRAS G12C-Mutant NSCLC: A Phase II Study

Efficacy and Safety of AK104 Combined With Chemotherapy and Cetuximab or Bevacizumab

Efficacy of Ustekinumab Therapy in Patients With Symptomatic Stricturing Crohn's Disease

Non-inferiority Study of the Effect of Non-cooling Blanket on Body Temperature in Patients With Heat Stroke

Randomized Phase II Trial: Chest Wall RT Omission After Prosthetic Reconstruction

Determination of the Effective Dose of a Single Intravenous Dose of Tegileridine Fumarate for Postoperative Analgesia After Orthopedic Surgery: A Up-and-Down Sequential Allocation Study

A Prospective Study of Anxiety, Depression, and Bipolar Disorder in People

Neoadjuvant Trastuzumab-rezetecan Plus Pertuzumab or Nab-Paclitaxel, Carboplatin, Trastuzumab, and Pyrotinib After Suboptimal Response to Neoadjuvant Dual HER2-Targeted Therapy Combined With Chemotherapy in HER2-Positive Early Breast Cancer

Auricular Point Stimulation Plus Dexamethasone for Nausea and Vomiting Caused by Docetaxel Plus Cyclophosphamide

A Study of Selinexor in Combination With Temozolomide and Anti-PD-1 Antibody in Patients With Relapsed/Refractory Primary Central Nervous System Lymphoma

Clinical Study of the Efficacy and Safety of Spinal Cord Stimulation in Patients With Limb Motor Dysfunction Following Stroke

Pucotenlimab Plus Radiotherapy and Chemotherapy for Neoadjuvant Treatment of Locally Advanced Rectal Cance(PUCRT)

Clinical Study of Endocardial Myocardial Biopsy

Clinical Study of Oncolytic Vaccinia VIrus Delivering Targeted CD19 in Vivo CAR-T/M Therapy for Refractory/Relapsed B-cell Lymphoma

Cognitive Impairment, Retinopathy, and Cerebrovascular Lesions in the Elderly

Immunoclassification of Psoriasis: a Strategy for Precision Medicine

A Trial for Minimally Invasive Neurosurgery With AI-assisted Robotic Guidance for Moderate Basal Ganglia Hemorrhage (RAINBOW-MBH)

Prophylactic Irradiation to the Contralateral Breast for BCAs Patients

Efficacy and Safety of Culmerciclib Plus Aromatase Inhibitors in a Response-Adapted Neoadjuvant Strategy for Highly Proliferative ER-Positive/HER2-Negative Breast Cancer

Intravenous Thrombolysis and NOAC